Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund
Agreement to provide up to $2.5 million CAD to Conavi Medical to support the commercial launch of the next-generation Novasight Hybrid system TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”),... Read More →
VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe
Strategic MOU enhances market access and extends reach to over 900 hospitals across the region SEOUL, South Korea, Oct. 28, 2025 /PRNewswire/ — VUNO Inc., a global medical AI company, announced today that it has signed a strategic Memorandum of... Read More →
PMcardio Reports Positive RCT Results and Late-Breaking Clinical Science for STEMI Detection
Queen of Hearts AI ECG Analysis Demonstrates Breakthrough Accuracy in STEMI Diagnosis Presented as Late-Breaking Science at TCT 2025 by Dr. Timothy D. Henry, simultaneously published in JACC: Cardiovascular Interventions San Francisco, October 28, 2025 — A new study presented... Read More →
LATTICE MEDICAL raises €43 million to transform post-cancer reconstruction
Lille, France, October 23, 2025 – LATTICE MEDICAL, a French Medtech company specializing in tissue engineering, announces a Series B fundraising round of €43 million, one of the largest of the year in the French Medtech sector. This major milestone... Read More →
PharmaJet® Tropis® Needle-free Injection System selected for Polio Immunization Campaign in Pakistan
GOLDEN, Colo. — October 23, 2025 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its innovative needle-free injection technology, today announced that their WHO prequalified Tropis ID Needle-free Injection System will be used... Read More →
Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling it featuring Armor Medical
A near-death experience with hemorrhage left a scientist searching for ways to detect serious blood loss early. Kelsey Mayo, CEO of Armor Medical, was sitting at her desk in 2019 when she passed out from severe pain. She had an... Read More →
NEUROMARK® Now with Expanded Access on UnitedHealthcare’s Medicare Advantage Policy for Posterior Nasal Nerve Ablation
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct. 22, 2025 /PRNewswire/ — Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that UnitedHealthcare’s... Read More →
Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology
PARSIPPANY, N.J., Oct. 21, 2025 /PRNewswire/ — Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, announced that it has recently received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ELEOS Proximal... Read More →
RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions
CHARLOTTESVILLE, Va., Oct. 21, 2025 /PRNewswire/ — RIVANNA®, developers of world-first imaging-based medical technologies, has been awarded with a Peer-Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) from the Congressionally Directed Medical Research Program (CDMRP). The award total from... Read More →
Subtle Medical Announces Positive Findings from Proof-of-Concept Study with Bayer Investigating AI To Lower Gadolinium Dose in CE-MRI
MENLO PARK, Calif., Oct. 21, 2025 /PRNewswire/ — Subtle Medical, Inc., a leader in AI-powered medical imaging solutions, today announced positive findings from a proof-of-concept (POC) study with Bayer, a leader in Radiology, evaluating Subtle Medical’s investigational SubtleGAD™ technology. The... Read More →